Hong Leong Investment Bank (HLIB) has downgraded its recommendation on Sunway Healthcare Holdings Bhd from "Buy" to "Hold," signaling that the stock's recent momentum may have run its course.
The research house maintained its target price at RM2.05, suggesting that the current valuation leaves little room for further appreciation in the near term.
The downgrade reflects a cautious stance on the healthcare operator following a period of strong price performance.
By shifting the rating to "Hold," HLIB indicates that while the company's fundamentals remain sound, the risk-reward profile has deteriorated for new entrants.
Investors who accumulated shares during the earlier rally may now face a period of consolidation rather than continued gains.
This move aligns with a broader shift in sentiment from the research house.